معرفی
Pieter J. Colin serves as an Associate Professor at the Faculty of Medical Sciences, University of Groningen, specializing in Pharmacokinetic Pharmacodynamic modelling (PKPD) within the Critical care, Anesthesiology, Peri-operative and Emergency medicine (CAPE) department. He holds significant external appointments as a Member of the Modelling and Simulation Working Party at the European Medicines Agency (EMA) since 2019 and as a Consultant Modelling and Simulation at the Belgian Federal Agency for Medicines and Health Products (FAMHP) since 2015.
Dr. Colin's research expertise spans pharmacokinetics, pharmacodynamics, and clinical pharmacology, with particular focus on modeling and simulation for drug development and clinical trial design. His fingerprint analysis reveals strong specialization in Pharmacokinetics (100%), Pharmacodynamics (56%), Normal Human pharmacology (43%), and specific drug areas including Propofol (33%), Paclitaxel (22%), Remimazolam (22%), and Remifentanil (20%). His work addresses critical questions in antibiotic therapy, anesthetic agents, and applications across diverse patient populations from premature infants to elderly patients.
Analysis of his recent publications (2024-2025) shows a clear trend toward model-informed drug development, particularly for regulatory submissions to the EMA. His research frequently involves complex pharmacokinetic-pharmacodynamic modeling for anesthesia and sedation drugs, with growing emphasis on pediatric applications and special populations including patients with kidney disease. The publications demonstrate sophisticated methodological approaches to population pharmacokinetic analysis and drug-disease modeling.
Dr. Colin actively contributes to academic discourse through his regulatory roles and as a supervisor for doctoral research, including the thesis of Johannes P van den Berg. His work bridges theoretical pharmacometrics with practical clinical applications in anesthesia and critical care medicine, influencing both research methodology and clinical practice guidelines.
He collaborates extensively with research teams focused on pharmacometric modeling and simulation, working closely with colleagues at the University Medical Center Groningen and international collaborators on multi-center pharmacokinetic studies. His activities include delivering specialized lectures on pharmacokinetics principles, serving as keynote speaker on model-informed approaches for pediatric drug development, and participating in leadership roles within the International Society of Anesthetic Pharmacology.
